首页> 外国专利> -5 3 Three-dimensional structure of human derived apoptotic factor and receptor thereof by X-ray chrystallography and TRAIL deletion mutant protein

-5 3 Three-dimensional structure of human derived apoptotic factor and receptor thereof by X-ray chrystallography and TRAIL deletion mutant protein

机译:-5 3 X射线晶体成像和TRAIL缺失突变蛋白对人源性凋亡因子及其受体的三维结构

摘要

PURPOSE: Provided are a three-dimensional structure of TRAIL-sDR5 complex of a human derived apoptotic factor and a receptor thereof by X-ray crystallography and TRAIL(TNF Related Apoptosis Inducing Ligand) deletion mutant protein. CONSTITUTION: TRAIL-sDR5 complex is prepared by mixing TRAIL protein of SEQ ID NO:1 and sDR5 protein of SEQ ID NO:2. It can be crystallization method comprises the steps of: injecting a solution consisting of 16% of polyethyleneglycol 3000, 0.05M of sodium acetate(pH 4.5), 0.22 M of sodium acetate and 0.6M of sodium chloride into a well; mixing the precipitation solution and protein solution in a mixing ratio of 1:1 on the surface of a cover slip; and covering the well with the cover slip to crystallize the protein.
机译:目的:通过X射线晶体学和TRAIL(TNF相关凋亡诱导配体)缺失突变蛋白,提供人源性凋亡因子及其受体的TRAIL-sDR5复合物的三维结构。组成:TRAIL-sDR5复合物是通过混合SEQ ID NO:1的TRAIL蛋白和SEQ ID NO:2的sDR5蛋白制备的。可以是将步骤:将由16%的聚乙二醇3000、0.05M的乙酸钠(pH 4.5),0.22M的乙酸钠和0.6M的氯化钠组成的溶液注入到孔中。在盖玻片的表面上以1:1的混合比混合沉淀溶液和蛋白质溶液。然后用盖玻片覆盖孔,使蛋白质结晶。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号